2don MSN
The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on ...
The agency is sitting on a decision to grant full approval for Novavax’s shot, days after top vaccine regulator pushed out.
Around 170 staff were cut from the FDA's Office of Inspections and Investigations this week as part of wider cuts at U.S.
2don MSN
Tracy Beth Hoeg, a sports medicine physician and epidemiologist who opposed key U.S. health policies during the COVID-19 ...
The delayed decision comes amid a major organizational shakeup that included the departure of top vaccine official Peter ...
The delay dovetails with moves by Republican lawmakers in at least seven states to ban or limit mRNA vaccines. Some, according to KFF Health News, are also pressing regulators to revoke federal ...
Amid a period of great upheaval at the agency, the FDA has missed its deadline to decide on approval for Novavax’s COVID-19 ...
More top vaccine regulators at the FDA have either left or been forced out, which could hobble the agency's ability to ...
Massive cuts at the FDA have hit staff tied to drug reviews and user fees, putting future approvals in jeopardy, according to ...
7don MSN
The top vaccine official with the Food and Drug Administration has resigned and criticized the nation's top health official ...
Novavax's COVID-19 vaccine received FDA Emergency Use Authorization, but full approval faces delays as regulators request more data beyond the April 1 deadline.
The U.S. Food and Drug Administration has missed its deadline for making a decision on traditional approval for Novavax's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results